Trimethoprim/Sulfamethoxazole
Sponsors
Baylor College of Medicine, National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina, Chapel Hill, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National University Hospital, Singapore
Conditions
Autoimmune DiseasesAutoimmune Inflammatory Rheumatic DiseaseChronic Kidney DiseaseComplicationConnective Tissue DiseaseCystic FibrosisHIV-1 InfectionInfection
Phase 1
Phase 2
Probiotics for Girls With Recurring Urinary Tract Infections
WithdrawnNCT00789464
Updated: 2020-08-18
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
TerminatedNCT01349192
Start: 2011-04-30End: 2015-05-31Updated: 2017-05-15
The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
CompletedNCT01595529
Start: 2012-05-18End: 2019-08-12Updated: 2020-08-06
Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
NCT01747278
Start: 2012-08-31End: 2013-08-31Target: 80Updated: 2012-12-11
Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole
NCT02734732
Start: 2015-04-30End: 2020-05-31Target: 2800Updated: 2019-05-15
Phase 3
Phase 4
Antibiotics for Klebsiella Liver Abscess Study
CompletedNCT01723150
Start: 2013-11-05End: 2018-01-16Updated: 2018-08-27
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
CompletedNCT03228108
Start: 2018-04-03End: 2021-09-26Updated: 2022-05-10
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
RecruitingNCT06499233
Start: 2024-07-20End: 2026-12-31Target: 800Updated: 2024-10-01